dexmedetomidine has been researched along with Edema, Pulmonary in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Han, DW; Han, Y; Lim, BJ; Oh, JE; Song, Y | 1 |
| Bo, L; Deng, X; Wang, C; Wang, H; Wang, Y; Zhang, D | 1 |
| Liu, Z; Wang, X; Yu, L; Zhang, Y | 1 |
| Li, C; Lv, C; Wang, Y; Xu, Y; Yin, X; Zhang, R; Zhang, X; Zhao, W | 1 |
| Liu, H; Liu, T; Wu, D; Yang, Y; Zhang, Q | 1 |
| Dai, ZL; Gao, LK; Huang, Q; Jiang, YX; Zhang, XP; Zhao, W | 1 |
| Chen, L; Cui, Y; Ding, Y; Li, Y; Li, YC; Nie, H | 1 |
| Horiguchi, T; Kumagai, M; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
| Hanci, V; Sipahi, EY; Turan, IÖ; Yurdakan, G; Yurtlu, S | 1 |
| Chen, YS; Huang, Z; Liu, JY; Yang, ZL | 1 |
| Kulkarni, A; Price, G; Saxena, M; Skowronski, G | 1 |
| Boller, J; Huhtinen, MK; Kästner, SB; Ohlerth, S; Pospischil, A | 1 |
1 trial(s) available for dexmedetomidine and Edema, Pulmonary
| Article | Year |
|---|---|
Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure.
Topics: Aged; Cohort Studies; Cross Infection; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Hypoxia; Intensive Care Units; Length of Stay; Male; Midazolam; Middle Aged; Noninvasive Ventilation; Prevalence; Pulmonary Edema; Treatment Failure; Treatment Outcome; Treatment Refusal | 2012 |
11 other study(ies) available for dexmedetomidine and Edema, Pulmonary
| Article | Year |
|---|---|
Dexmedetomidine attenuates subarachnoid hemorrhage-induced acute lung injury through regulating autophagy and TLR/NFκB signaling pathway.
Topics: Acute Lung Injury; Animals; Autophagy; Dexmedetomidine; Interleukin-6; Male; NF-kappa B; Pulmonary Edema; Rats; Rats, Wistar; Signal Transduction; Subarachnoid Hemorrhage; Toll-Like Receptor 4; Toll-Like Receptor 9 | 2022 |
Dexmedetomidine Protects Against Traumatic Brain Injury-Induced Acute Lung Injury in Mice.
Topics: Acute Lung Injury; Animals; Brain Injuries, Traumatic; Bronchoalveolar Lavage Fluid; Dexmedetomidine; HMGB1 Protein; Lung; Male; Mice; Mice, Inbred C57BL; Models, Animal; Protective Agents; Pulmonary Edema; Receptor for Advanced Glycation End Products; Signal Transduction | 2018 |
Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR-381.
Topics: Acute Lung Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caspase 1; Cytokines; Dexamethasone; Dexmedetomidine; Gene Expression Regulation; Lipopolysaccharides; Lung; Male; Mice, Inbred C57BL; MicroRNAs; NLR Family, Pyrin Domain-Containing 3 Protein; Protective Agents; Proteolysis; Pulmonary Edema; Random Allocation; RNA Interference | 2018 |
Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Inflammation Mediators; Lipopolysaccharides; Lung; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Neutrophil Infiltration; Phosphorylation; Pulmonary Edema; Time Factors; Transcription Factors; Transcription, Genetic | 2015 |
Effects of dexmedetomidine on the protection of hyperoxia-induced lung injury in newborn rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Animals, Newborn; Aquaporin 1; Cytokines; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Hyperoxia; Inflammation Mediators; Lung; Lung Injury; Macrophages; Pneumonia; Pulmonary Edema; Rats, Sprague-Dawley | 2015 |
Dexmedetomidine alleviates pulmonary edema by upregulating AQP1 and AQP5 expression in rats with acute lung injury induced by lipopolysaccharide.
Topics: Acute Lung Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Aquaporin 1; Aquaporin 5; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Gene Expression Regulation; Injections, Intravenous; Interleukin-1beta; Lipopolysaccharides; Lung; Male; Organ Size; Pulmonary Edema; Rats; Rats, Wistar; Signal Transduction; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2015 |
Dexmedetomidine enhances human lung fluid clearance through improving alveolar sodium transport.
Topics: Biological Transport; Bronchoalveolar Lavage Fluid; Cell Line; Dexmedetomidine; Dose-Response Relationship, Drug; Humans; Lung; Organ Culture Techniques; Pulmonary Alveoli; Pulmonary Edema; Respiratory Mucosa; Sodium | 2017 |
Intravenous dexmedetomidine decreases lung permeability induced by intracranial hypertension in rats.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Capillary Permeability; Dexmedetomidine; Hemodynamics; Infusions, Intravenous; Intracranial Hypertension; Lung; Male; Microcirculation; Pulmonary Edema; Rats; Rats, Sprague-Dawley | 2008 |
Protective effect of dexmedetomidine in a rat model of α-naphthylthiourea-induced acute lung injury.
Topics: Acute Lung Injury; Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Disease Models, Animal; Drug Interactions; Lung; Male; Pleural Effusion; Pneumonia; Pulmonary Edema; Rats; Rats, Wistar; Rodenticides; Thiourea | 2012 |
Difficult extubation: calming the sympathetic storm.
Topics: Aged; Conscious Sedation; Device Removal; Dexmedetomidine; Humans; Hypertension; Hypnotics and Sedatives; Intubation, Intratracheal; Male; Myocardial Infarction; Propofol; Pulmonary Edema; Stress, Physiological; Sympathetic Nervous System; Tachycardia; Ventricular Dysfunction, Left | 2004 |
Dexmedetomidine-induced pulmonary alterations in sheep.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Animals; Blood Pressure; Dexmedetomidine; Dinoprostone; Inflammation; Lung; Nitric Oxide; Oxygen; Polymerase Chain Reaction; Pulmonary Edema; Sheep; Sheep Diseases; Vasoconstriction | 2007 |